Top Markets
#1 Akedo Akedo +62.21%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.61%
#4 Cross Cross +42.54%
#5 Black Phoenix Black Phoenix +34.09%
#6 Velvet Velvet +30.86%
#7 OVERTAKE OVERTAKE +24.86%
#8 Cap Cap +16.59%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.42%
#10 Bitway Bitway +12.57%
Coin of the day
Akedo Akedo
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
शेयरों में रैंक #39468
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
शेयर मूल्य
$0.11725176
अंतिम समन्वयन: 2025-07-14
मार्केट कैप
$481.50K
बदलाव (1 दिन)
-0.20%
बदलाव (1 वर्ष)
0.00%
देश
FR
व्यापार PHAXIAM Therapeutics S.A. (PHXM)

श्रेणी

Healthcare
PHAXIAM Therapeutics S.A. (PHXM) के लिए कमाई
Jun 2024 में कमाई TTM: $-23.51M
PHAXIAM Therapeutics S.A. की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान कमाई $-23.51M है। 2022 में कंपनी ने $-1.28M की कमाई की, जो 2021 की कमाई $-65.34M के की वृद्धि है। इस पृष्ठ पर दिखाई गई कमाई ब्याज और कर से पहले की कमाई है, जिसे EBIT कहा जाता है।
PHAXIAM Therapeutics S.A. के लिए कमाई का इतिहास 2016 से 2026 तक
प्रत्येक वर्ष के अंत में कमाई
वर्ष कमाई परिवर्तन
2026 (TTM) $-23.51M -14.00%
2023 $-27.34M 2,036.64%
2022 $-1.28M -98.04%
2021 $-65.34M -30.07%
2020 $-93.44M 25.10%
2019 $-74.70M 52.60%
2018 $-48.95M 11.10%
2017 $-44.06M 64.85%
2016 $-26.73M 0.00%
समान कंपनियों या प्रतियोगियों की कमाई
कंपनी कमाई कमाई में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -22,533.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -8,395.72%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -12,882.70%
BE